115 related articles for article (PubMed ID: 28618736)
1. Frequency of human parvovirus 4 (PARV4) viremia among HBV-infected patients and healthy donors in Shiraz, Iran.
Amirahmadi F; Sarvari J; Hosseini SY; Pirbonyeh N; Gorzin AA
Turk J Med Sci; 2017 Jun; 47(3):868-873. PubMed ID: 28618736
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
[TBL] [Abstract][Full Text] [Related]
3. First report of human parvovirus 4 detection in Iran.
Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
[TBL] [Abstract][Full Text] [Related]
4. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
Manning A; Willey SJ; Bell JE; Simmonds P
J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of human parvovirus B19, bocavirus, and PARV4 in blood samples from the general population of China and lack of a correlation between parvovirus and hepatitis B co-infection.
Tong R; Shen L; Yin W; Zhou W; Lu J; Zheng M; Bi S; Lou Y; Tan W
PLoS One; 2013; 8(5):e64391. PubMed ID: 23737981
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
7. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
[TBL] [Abstract][Full Text] [Related]
8. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).
Corcioli F; Zakrzewska K; Fanci R; De Giorgi V; Innocenti M; Rotellini M; Di Lollo S; Azzi A
Virol J; 2010 Oct; 7():272. PubMed ID: 20950445
[TBL] [Abstract][Full Text] [Related]
9. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens.
Botto S; Bergallo M; Sidoti F; Terlizzi ME; Astegiano S; Ponti R; Costa C; Cavallo R
New Microbiol; 2009 Apr; 32(2):189-92. PubMed ID: 19579698
[TBL] [Abstract][Full Text] [Related]
10.
Rastegarpouyani H; Mohebbi SR; Hosseini SM; Azimzadeh P; Beyraghie S; Sharifian A; Asadzadeh-Aghdaei H; Arshi S; Zali MR
Gastroenterol Hepatol Bed Bench; 2018; 11(2):138-144. PubMed ID: 29910855
[TBL] [Abstract][Full Text] [Related]
11. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
13. Persistence of novel human parvovirus PARV4 in liver tissue of adults.
Schneider B; Fryer JF; Reber U; Fischer HP; Tolba RH; Baylis SA; Eis-Hübinger AM
J Med Virol; 2008 Feb; 80(2):345-51. PubMed ID: 18098166
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
15. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
16. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
Chen MY; Hung CC; Lee KL
Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
[TBL] [Abstract][Full Text] [Related]
17. Human parvovirus 4 prevalence among HTLV-1/2 infected individuals in Brazil.
Slavov SN; Otaguiri KK; Smid J; de Oliveira AC; Casseb J; Martinez EZ; Covas DT; Eis-Hübinger AM; Kashima S
J Med Virol; 2017 Apr; 89(4):748-752. PubMed ID: 27589576
[TBL] [Abstract][Full Text] [Related]
18. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
19. Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.
Chenari M; Norouzi M; Ghalichi L; Rezaee A; Yari A; Alavian SM; Jazayeri SM
J Med Virol; 2014 Nov; 86(11):1861-7. PubMed ID: 25132488
[TBL] [Abstract][Full Text] [Related]
20. Human Parvovirus 4: A harmless bystander or a pathogen of severe acute respiratory illness.
Prakash S; Shukla S; Ramakrishna V; Mishra H; Bhagat AK; Jain A
Int J Infect Dis; 2020 Jan; 90():21-25. PubMed ID: 31605808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
